In our cohort, we did observe that PKD1 is down-regulated in primary breast tumors as compared to normal breast tissue (data not shown) and we also showed that high PRKD1 mRNA levels are predictive of a poorer prognosis in both the entire cohort and the TNBC subgroup. The gene discussed is PRKD1; the disease is breast neoplasm.